User:Mr. Ibrahem/Mitapivat

Mitapivat, sold under the brand name Pyrukynd, is a medication used to treat hemolytic anemia in those with pyruvate kinase deficiency. It is approved in adults. It is taken by mouth.

Common side effects include trouble sleeping, back pain, nausea, and joint pain. Safety in pregnancy is unclear. It is a pyruvate kinase activator.

Mitapivat was approved for medical use in the United States and Europe in 2022. In the United States 4 weeks of treatment costs about 27,000 USD as of 2022. It is not commercially available in the United Kingdom as of 2022.